Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation
NCT: NCT03561805 · ACTIVE_NOT_RECRUITING
Brief Summary
Patients with severe aortic stenosis candidates for a TAVI procedure harbor a high burden of silent arrhythmic events. Pre-procedural detection of such arrhythmias should help the investigators to implement specific therapeutic measures that may improve patient outcomes and reduce hospitalization length post-TAVI.
Frequently Asked Questions
What is Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation?
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation is a clinical trial registered under NCT03561805. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03561805?
The current status of NCT03561805 (Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation) is: ACTIVE_NOT_RECRUITING.
When did Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation start?
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation started on 2017-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.